Project Grant S15OD042583
Award Date 9/1/26
Completion Date 8/31/27
Dollars Obligated $350K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ithaca, NY 14853, USA
Similar Awards
- The National Institutes of Health Office of the Director awarded the University of Delaware $349,827 on August 15, 2026, under the Research Infrastructure Programs (CFDA 93.351) to procure and install individually ventilated caging (IVC) systems and filtered animal handling transfer cabinets at the Life Sciences Research Facility (LSRF) in Newark, Delaware. The LSRF, which serves over 30 principal investigators and multiple NIH-funded programs, has experienced 70 percent growth in animal housing...
- The National Institute of Allergy and Infectious Diseases awarded Cornell University $219,852 on May 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate the bacterial endosymbiont accommodation program in early-divergent mucoromycete fungi. The research tests the hypothesis that fungi harbor a common developmental program for accommodating bacterial endosymbionts. The work will examine principles governing the establishment and maintenance of...
- The National Institute of Allergy and Infectious Diseases awarded $456,500 to The University of Texas Southwestern Medical Center on April 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop a reproducible sequential infection model that matures laboratory mouse immune responses. The research will define a minimal set of sequential viral and parasitic infections that laboratory mice can be exposed to early in life to recapitulate aspects of wild mice...
- The National Institute of General Medical Sciences awarded Cornell University $375,154 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to uncover the structure and function of understudied membrane proteins implicated in human disease. The research employs C. elegans as a model organism to systematically examine protein structure, interactome, expression patterns, and associated animal behavior. Over the five-year performance period (through February...
- The National Institute of Allergy and Infectious Diseases awarded Cornell University $233,441 on July 17, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to identify genetic drivers of CD8+ T cell activation and proliferation. The project extends through June 30, 2028, with performance at Cornell's location in New York. The research uses the Diversity Outbred mouse model to investigate how genetic variation influences CD8+ T cell behavior across multiple...
- The National Institute of Allergy and Infectious Diseases awarded Weill Medical College of Cornell University $211,875 on February 20, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and test conditional knockdown mutants of Mycobacterium tuberculosis in C3HEB/FEJ mice with human-like tuberculosis pathology. The research analyzes conditional mutants deficient in thioredoxin reductase (TRXB2) and biotin protein ligase (BPL) to determine their ability to...
- The National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, awarded Cornell University $1,086,266 on May 7, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop systems-level understanding of beta-lactam antibiotic mechanism of action. The award funds development of a peptidoglycan architecture analysis pipeline to assess bacterial cell wall turnover in high-throughput fashion, establishment of novel...
- The National Institutes of Health Office of the Director awarded The Trustees of Columbia University in the City of New York $350,000 on September 1, 2026, under the Research Infrastructure Programs (CFDA 93.351) to modernize sterilization infrastructure at the Irving Cancer Research Center vivarium. Columbia will replace a bulk steam autoclave with a Gruenberg Steri-Dry bulk dry-heat sterilizer to sterilize cages supporting barrier housing for patient-derived xenografts, immunocompromised and...
- Federal Project Grant Award Summary Cornell University's Office of Sponsored Programs received a $1.84 million Project Grant from the National Institute of Environmental Health Sciences under the Medical Library Assistance program (CFDA 93.879) awarded on September 5, 2025, with completion scheduled for August 31, 2029. The research project, "Data-Driven Discovery of Host-Microbiome Protein-Protein Interactions," delivers a computational pipeline and analytical tools designed to...
- The National Institute of General Medical Sciences awarded Cornell University $291,491 on April 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support research on autolysin function in gram-negative bacterial growth and morphogenesis. The research addresses regulation of peptidoglycan-cleaving enzymes (endopeptidases and lytic transglycosylases) that enable bacterial cell wall remodeling during growth. These autolysins represent potential antibiotic targets...